Acute chest syndrome (sickle cell)
Sickle emergency · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A new lung infiltrate with chest pain and hypoxia in sickle cell disease, which can deteriorate fast. Oxygen, analgesia, antibiotics and transfusion are key.
Figures & algorithms
Assessment
Investigations
- Chest X-ray
- FBC and reticulocytes
- Oxygen saturations and cultures
Management
- Oxygen and analgesia
- Co-amoxiclav 1.2 g IV TDS + clarithromycin 500 mg BD — BNF
- Hydration
- Simple/exchange transfusion (haematology-led)
- Critical-care if severe
Drugs & doses
Co-amoxiclav 1.2 g IV TDS + clarithromycin 500 mg BD — BNF
Disposition
Admit; haematology.
A new infiltrate with hypoxia in sickle cell disease is acute chest syndrome. Antibiotic doses per BNF (current edition); confirm choice in the in-app Antibiotic Dosing tool.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.
